治疗注射剂：设备、产品、市场

本报告研究了注射治疗产品市场，并提供了市场概况、细分趋势、新兴技术趋势、市场预测以及进入市场的公司概况。

内容

执行摘要

• 市场机会
• 配送市场动态
• 注射药物的经济学
• 推动注射装置增长的因素
• 预充式註射器快速增长
• 预灌封注射器供应链
• 自我管理的倾向
• 人口统计数据的变化
• 一次性设备设计的创新
• 生物製剂的流行程度
• 治疗性单克隆抗体
• 风险因素
• 注射装置概要
• 自动注射器

单次固定剂量

可变剂量

双室

无线自动注射器

• BETACONNECT（拜耳）
• RebiSmart（默克雪兰诺）

主要产品

自动注射器

自动注射装置设计元素

• 材料选择问题
• 零件数量和设备成本
• 安全功能
• 针插入深度
• 故障保护激活
• 产能检查/注入确认

市场因素

• 冻干药物/重构
• 人体工程学/人体工程学

笔式註射器

商业笔产品

甲状旁腺激素

• 福特奥彭
• Pretact/Preos
• 纳帕拉

生殖激素

• Foristim/Pure Gonpen
• 戈纳列夫

可穿戴设备 - 分析和评估

新兴技术

• 无线数据

注射剂市场分析及预测

• 自身免疫性疾病
  • 类风湿性关节炎
  • 牛皮癣
  • 多发性硬化症
• 造血作用
  • 荷尔蒙
  • 骨质疏鬆症
  • 生育能力

市场因素

• 监管问题
• 设备品牌
• 患者的依从性和可用性
• 医疗保健经济学

公司简介

“Therapeutic Injectable Drug: Devices, Products and Markets” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for therapeutic injectable drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

What You Will Learn:

• Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.

• Assesses key markets, market dynamics and market demographics.

• Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.

• Provides market data and forecasts.

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on drug product commercialization.

• Evaluates the impact of economic, technology, and regulatory factors.

Table of Contents

Executive Summary

• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Prefilled Syringe Supply Chain
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Risk Factors
• Injectable Drug Device Summaries
• Autoinjectors

Single Fixed Dose

• Molly (SHL Medical)
• Molly RNS (SHLMedical)
• Bertha (SHL Medical)
• Maggie (SHL Medical)
• Amber (SHL Medical)
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• DAI (SHL Medical)
• DI 2 (SHL medical)
• Flexi-Q PFS (Elcam Medical)
• Physioject (Becton DIckinson
• Intevia (Becton Dickinson)

Variable Dosing

• VSDI + NIT
• Ypsomed VarioJect
• High Viscosity
• Rotaject Technology (SHL Medical)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

Dual Chamber

Wirelessly Enabled Autoinjectors

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

Selected Product Specific

Autoinjectors

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

Autoinjector Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation

Market Factors

• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo (Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

Parathyroid Hormone

• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Follistim/Puregon Pen
• Gonal-f

Wearable Devices - Analysis and Assessments

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)

Emerging Technology

• Wireless Data

Injectable Drug Market Analysis and Forecasts

• Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis

• Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics

Company Profiles